Hydroxychloroquine for treatment of non‐hospitalized adults with COVID‐19: A meta‐analysis of individual participant data of randomized trials

• Main Authors: Oriol Mitjà (Author), Gilmar Reis (Author), David R. Boulware (Author), Adam M. Spivak (Author), Ammar Sarwar (Author), Christine Johnston (Author), Brandon Webb (Author), Michael D. Hill (Author), Davey Smith (Author), Peter Kremsner (Author), Marla Curran (Author), David Carter (Author), Jim Alexander (Author), Marc Corbacho (Author), Todd C. Lee (Author), Katherine Huppler Hullsiek (Author), Emily G. McDonald (Author), Rachel Hess (Author), Michael Hughes (Author), Jared M. Baeten (Author), Ilan Schwartz (Author), Luanne Metz (Author), Lawrence Richer (Author), Kara W. Chew (Author), Eric Daar (Author), David Wohl (Author), Michael Dunne (Author)
• Format: Book
• Published: Wiley, 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Hydroxychloroquine (HCQ) was initially promoted as an oral therapy for early treatment of coronavirus disease 2019 (COVID‐19). Conventional meta‐analyses cannot fully address the heterogeneity of different designs and outcomes of randomized controlled trials (RCTs) assessing the efficacy of...